Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Eylea sales will tumble as brolucizumab gains traction

Following Regeneron’s announcement that the FDA issued a complete response letter (CRL) regarding its supplemental Biologics License Application (sBLA) of the 12-week injection dosing for Eylea (aflibercept) in patients with wet age-related macular degeneration (wet AMD), the labeling issue will likely heat already anticipated competition with rival Novartis’ new wet AMD drug, brolucizumab. Edit Kovalcsik, […]
Read more

T-Mobile’s ‘Un-carrier’ customer care move hints at its forthcoming pay-TV strategy

Following yesterday’s news (Wednesday 15 August) that T-Mobile USA is overhauling its customer care with a human-centered approach called ‘Team of Experts’, Tammy Parker, Senior Technology Analyst at GlobalData, a leading data and analytics company, offers her view: “Promoting strong customer support as an Un-carrier feature hints at part of T-Mobile’s planned strategy for challenging […]
Read more

Samsung’s Galaxy Note9 is a technical powerhouse, but is too similar to the Note8 – and too expensive – to grow market share

Following yesterday’s news (Thursday 9 August) from Samsung’s Unpacked event, Avi Greengart, Research Director for Consumer Platforms and Devices at GlobalData, a leading data and analytics company, offers his view on the Galaxy Note9, Galaxy Watch, Galaxy Home, and new partnership with Spotify: Galaxy Note9 “The new Galaxy Note9 has top-of-the-line specs along with extras […]
Read more

North Americans are the least informed about GDPR in Pharma

North Americans were the least likely to say that they feel informed about the requirements of the General Data Protection Regulation (GDPR) out of those surveyed in the global pharmaceuticals industry, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘GDPR in the Healthcare Industry’ states that only 54% of North […]
Read more

GDPR has had a greater impact on R&D in healthcare compared to other industries

R&D departments in healthcare organisations have felt a significantly higher impact due to the General Data Protection Regulation (GDPR) than in other sectors, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘GDPR in the Healthcare Industry’ finds that, whilst most business departments have been affected similarly regardless of which sector […]
Read more

Card infrastructure is showing its age

Following the news (Thursday 2 August) that NatWest debit cards were unusable for two hours this afternoon, Sam Murrant, Senior Payments Analyst at GlobalData, a leading data and analytics company, offers his view on the future of card-based payments: “The payments industry is increasingly moving towards an assumption that we will pay for everything electronically […]
Read more

Interest rate rise is another unwelcome dampener on retail spend

Following today’s (Thursday 2 August) increase in UK interest rates, Patrick O’Brien, UK Retail Research Director at GlobalData, a leading data and analytics company, offers his view: “While the Bank of England believes that the UK economy is in strong enough shape to withstand an interest rate increase, UK retailers will be scratching their heads, […]
Read more

Launch of Aimovig signals the start of a boom in the European migraine market

Following the launch of Novartis’ anti-migraine drug, Aimovig, in Europe, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on the potential growth of the market: “The calcitonin gene-related peptide (CGRP) monoclonal antibody class has generated significant excitement among headache specialists since posting promising efficacy results in early stage […]
Read more

Takeda will be looking to Shire’s drug pipeline to bolster future sales after disappointing Q1 results

Following the announcement of a significant dip in first-quarter operating profit for Takeda, Thomas Moore, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on the company’s future: “Takeda’s first-quarter operating profits took a 49% hit year-on-year, and represent the weakest first quarter profit in the last three years. Looking […]
Read more

Merck KGaA looking to become a key player in the multiple sclerosis market as the FDA accept Mavenclad for review

Following the announcement that the FDA have accepted Merck KGaA’s resubmitted application for Mavenclad, seven years after the original application, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on the company’s current progress: “Merck KGaA have placed themselves in a strong position in the multiple sclerosis market with […]
Read more

Cash is not dead yet

Following the announcement (Friday 27 July) that there will be a review for cash access after a surge in digital payments, Sam Murrant, Senior Payments Analyst at GlobalData, a leading data and analytics company, offers his view on the future of cash payments: “Cash in the UK is by no means as dead or dying […]
Read more

Facebook growth is beginning to stall and the future lies in Instagram, WhatsApp and Messenger

Following yesterday’s news (Wednesday 25 July) of Facebook’s lower-than-expected Q2 earnings: Lynnette Luna, Principal Analyst at GlobalData, a leading data and analytics company, offers her view on Facebook’s current challenges: “Facebook’s missed expectations on revenues and user growth and management’s warning that revenue growth rates would decelerate in the next two quarters, likely reflect more […]
Read more

Quorn’s investments in vegan foods is further evidence that veganism successfully captures consumers’ secondary dieting concerns

Following yesterday’s news (Monday 23 July) that Quorn is to invest a further £7m in R&D to create more vegan products, Will Grimwade, Associate Analyst at GlobalData, a leading data and analytics company, suggests this is indicative of a wider trend: “Quorn’s decision to continue to orientate their new products towards the vegan market is […]
Read more
1 … 89 90 91 92 93